drugset / Trial / NCT06439368
Effect of Dezocine Combined With Sufentanil on the Quality of Postoperative Recovery and Analgesic Effect in Patients Undergoing Thoracic Surgery
Phase 4
Unknown
210 enrolled
Yangtze River Pharmaceutical Group Co., Ltd.
Nanfang Hospital, Southern Medical University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this clinical trial is to evaluate the effect of dezocine combined with sufentanil on postoperative recovery quality and analgesic effect in patients undergoing thoracic surgery. It will also learn about the safety of dezocine. Researchers will compare drug dezocine to Sufentanil to see if dezocine works to Improve postoperative pain and recovery quality for patients. Participants will undergo elective surgery and receive PCIA postoperatively，taking dezocine combine with sufentanil,or only sufentanil respectively. Visit the VAS score after connecting the analgesic pump 24h and 48h，and evaluate the Quality of Recovery -15 score.
Timeline
- Start
- 2023-01-05
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dezocine | Other / unclassified | 1 mg/kg | — |
| Subject | Sufentanil | Other / unclassified | 2 ug/kg | — |
| Subject | Sufentanil | Other / unclassified | 3 ug/kg | — |
Indications
No indication recorded.